IBDEI1AX ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23308,2)
 ;;=^266859
 ;;^UTILITY(U,$J,358.3,23309,0)
 ;;=111.0^^148^1443^7
 ;;^UTILITY(U,$J,358.3,23309,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23309,1,2,0)
 ;;=2^111.0
 ;;^UTILITY(U,$J,358.3,23309,1,5,0)
 ;;=5^Tinea Versicolor
 ;;^UTILITY(U,$J,358.3,23309,2)
 ;;=^119758
 ;;^UTILITY(U,$J,358.3,23310,0)
 ;;=706.8^^148^1444^1
 ;;^UTILITY(U,$J,358.3,23310,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23310,1,2,0)
 ;;=2^706.8
 ;;^UTILITY(U,$J,358.3,23310,1,5,0)
 ;;=5^Asteatotic Eczema
 ;;^UTILITY(U,$J,358.3,23310,2)
 ;;=^271931
 ;;^UTILITY(U,$J,358.3,23311,0)
 ;;=691.8^^148^1444^5
 ;;^UTILITY(U,$J,358.3,23311,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23311,1,2,0)
 ;;=2^691.8
 ;;^UTILITY(U,$J,358.3,23311,1,5,0)
 ;;=5^Intrinsic Eczema
 ;;^UTILITY(U,$J,358.3,23311,2)
 ;;=^87342
 ;;^UTILITY(U,$J,358.3,23312,0)
 ;;=692.9^^148^1444^8
 ;;^UTILITY(U,$J,358.3,23312,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23312,1,2,0)
 ;;=2^692.9
 ;;^UTILITY(U,$J,358.3,23312,1,5,0)
 ;;=5^Xerotic Eczema
 ;;^UTILITY(U,$J,358.3,23312,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,23313,0)
 ;;=686.8^^148^1444^6
 ;;^UTILITY(U,$J,358.3,23313,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23313,1,2,0)
 ;;=2^686.8
 ;;^UTILITY(U,$J,358.3,23313,1,5,0)
 ;;=5^Pustular Eczema
 ;;^UTILITY(U,$J,358.3,23313,2)
 ;;=^88097
 ;;^UTILITY(U,$J,358.3,23314,0)
 ;;=690.18^^148^1444^7
 ;;^UTILITY(U,$J,358.3,23314,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23314,1,2,0)
 ;;=2^690.18
 ;;^UTILITY(U,$J,358.3,23314,1,5,0)
 ;;=5^Seborrheic Eczema
 ;;^UTILITY(U,$J,358.3,23314,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,23315,0)
 ;;=705.81^^148^1444^3
 ;;^UTILITY(U,$J,358.3,23315,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23315,1,2,0)
 ;;=2^705.81
 ;;^UTILITY(U,$J,358.3,23315,1,5,0)
 ;;=5^Dyshidrotic Eczema/Pompholyx
 ;;^UTILITY(U,$J,358.3,23315,2)
 ;;=Dyshidrotic Eczema/Pompholyx^96545
 ;;^UTILITY(U,$J,358.3,23316,0)
 ;;=692.9^^148^1444^2
 ;;^UTILITY(U,$J,358.3,23316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23316,1,2,0)
 ;;=2^692.9
 ;;^UTILITY(U,$J,358.3,23316,1,5,0)
 ;;=5^Atopic Eczema
 ;;^UTILITY(U,$J,358.3,23316,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,23317,0)
 ;;=274.89^^148^1444^4
 ;;^UTILITY(U,$J,358.3,23317,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23317,1,2,0)
 ;;=2^274.89
 ;;^UTILITY(U,$J,358.3,23317,1,5,0)
 ;;=5^Gouty Eczema
 ;;^UTILITY(U,$J,358.3,23317,2)
 ;;=^267936
 ;;^UTILITY(U,$J,358.3,23318,0)
 ;;=782.3^^148^1445^3
 ;;^UTILITY(U,$J,358.3,23318,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23318,1,2,0)
 ;;=2^782.3
 ;;^UTILITY(U,$J,358.3,23318,1,5,0)
 ;;=5^Pitting Edema
 ;;^UTILITY(U,$J,358.3,23318,2)
 ;;=^38340
 ;;^UTILITY(U,$J,358.3,23319,0)
 ;;=459.2^^148^1445^2
 ;;^UTILITY(U,$J,358.3,23319,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23319,1,2,0)
 ;;=2^459.2
 ;;^UTILITY(U,$J,358.3,23319,1,5,0)
 ;;=5^Edema d/t Venous Obstruction
 ;;^UTILITY(U,$J,358.3,23319,2)
 ;;=^269850
 ;;^UTILITY(U,$J,358.3,23320,0)
 ;;=457.1^^148^1445^1
 ;;^UTILITY(U,$J,358.3,23320,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23320,1,2,0)
 ;;=2^457.1
 ;;^UTILITY(U,$J,358.3,23320,1,5,0)
 ;;=5^Edema d/t Lymphatic Obstruction
 ;;^UTILITY(U,$J,358.3,23320,2)
 ;;=^87693
 ;;^UTILITY(U,$J,358.3,23321,0)
 ;;=695.2^^148^1446^2
 ;;^UTILITY(U,$J,358.3,23321,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23321,1,2,0)
 ;;=2^695.2
 ;;^UTILITY(U,$J,358.3,23321,1,5,0)
 ;;=5^Erythema Nodosum
 ;;^UTILITY(U,$J,358.3,23321,2)
 ;;=^42065
 ;;^UTILITY(U,$J,358.3,23322,0)
 ;;=692.71^^148^1446^3
 ;;^UTILITY(U,$J,358.3,23322,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23322,1,2,0)
 ;;=2^692.71
